Refreshing results…
IDH1/2 inhibitor monotherapy in blast‐phase myeloproliferative neoplasms: A multicentre experience
UploadChronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases
Download from doi.orgMissing publications? Search for publications with a matching author name.